How do I buy Zevra Therapeutics (ZVRA) stock?

You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.View our list of the best stock brokerages

Who are Zevra Therapeutics (ZVRA) competitors?

Other companies in Zevra Therapeutics’s space includes: SNDL Inc (NASDAQ:SNDL), Bioage Labs Inc (NASDAQ:BIOA), NervGen Pharma Corp (NASDAQ:NGEN), Neumora Therapeutics Inc (NASDAQ:NMRA) and Aardvark Therapeutics Inc (NASDAQ:AARD).

What is the forecast, or price target, for Zevra Therapeutics (ZVRA) stock?

Zevra Therapeutics has a consensus price target of $21.36.

What is the current price for Zevra Therapeutics (ZVRA)?

The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $9.25 last updated January 23, 2026 at 6:43 AM EST.

Does Zevra Therapeutics (ZVRA) pay a dividend?

There are no upcoming dividends for Zevra Therapeutics.

When is Zevra Therapeutics (NASDAQ:ZVRA) reporting earnings?

Zevra Therapeutics does not have any upcoming earnings scheduled.

Is Zevra Therapeutics (ZVRA) going to split?

There is no upcoming split for Zevra Therapeutics.

What sector and industry does Zevra Therapeutics (ZVRA) operate in?

Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Zevra Therapeutics (ZVRA) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people...

Comments